Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime.
Nolan
Charles M
CM
D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016903:Drug Monitoring; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use*; D012449:Safety; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000517:prevention & control*
D000995:Antitubercular Agents; D007538:Isoniazid